Literature DB >> 7007449

Comparison of ELISA and RIA for measurement of pneumococcal antibodies before and after vaccination with 14-valent pneumococcal capsular polysaccharide vaccine.

M Koskela, M Leinonen.   

Abstract

Antibody responses to the 14-valent pneumococcal capsular polysaccharide vaccine in children under school age were measured by enzyme-linked immunosorbent assay (ELISA) and radioimmunoassay (RIA). Specific IgG and IgM antibodies were usually detectable by ELISA in the prevaccination sera, and one or both of them increased as a response to the vaccination. Specific IGA antibodies were detected by ELISA in a part of the post-vaccination sera only. The frequency of the IgA responses increased with the age of the children. The correlation of the ELISA results with RIA was good (r from 0.652 to 0.812) except for type 6A (r = 0.471).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7007449      PMCID: PMC1146421          DOI: 10.1136/jcp.34.1.93

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

1.  Studies in human subjects of polyvalent pneumococcal vaccines (39894).

Authors:  R E Weibel; P P Vella; A A McLean; A F Woodhour; W L Davidson; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1977-10

2.  Vaccination and revaccination with polyvalent pneumococcal polysaccharide vaccines in adults and infants.

Authors:  J M Borgoño; A A McLean; P P Vella; A F Woodhour; I Canepa; W L Davidson; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1978-01

3.  The enzyme-linked immunosorbent assay (ELISA): a measure of antibody concentration or affinity.

Authors:  J E Butler; T L Feldbush; P L McGivern; N Stewart
Journal:  Immunochemistry       Date:  1978-02

4.  Pneumococcal antibodies in IgA of serum and external secretions.

Authors:  R P Mouton; J W Stoop; R E Ballieux; N A Mul
Journal:  Clin Exp Immunol       Date:  1970-08       Impact factor: 4.330

5.  Solid phase antibody assay by means of enzyme conjugated to anti-immunoglobulin.

Authors:  P Leinikki; S Pässilä
Journal:  J Clin Pathol       Date:  1976-12       Impact factor: 3.411

6.  Pneumococcal antibodies in maxillary sinus secretion.

Authors:  C Carenfelt
Journal:  Scand J Infect Dis       Date:  1977

7.  Determination of antibody to pneumococcal polysaccharides with chromic chloride-treated human red blood cells and indirect hemagglutination.

Authors:  A J Ammann; R J Pelger
Journal:  Appl Microbiol       Date:  1972-11

8.  Immune response to acute otitis media in children. I. Serotypes isolated and serum and middle ear fluid antibody in pneumococcal otitis media.

Authors:  J L Sloyer; V M Howie; J H Ploussard; A J Ammann; R Austrian; R B Johnston
Journal:  Infect Immun       Date:  1974-06       Impact factor: 3.441

9.  Use of erythrocytes sensitized with purified pneumococcal polysaccharides for the assay of antibody and antibody-producing cells.

Authors:  P J Baker; P W Stashak; B Prescott
Journal:  Appl Microbiol       Date:  1969-03

10.  Immunoglobulins of the middle ear fluid in acute otitis media: relationship to serum immunoglobulin concentrations and bacterial cultures.

Authors:  V M Howie; J H Ploussard; J L Sloyer; R B Johnston
Journal:  Infect Immun       Date:  1973-04       Impact factor: 3.441

View more
  16 in total

1.  A strong antibody response to the periplasmic C-terminal domain of the OmpA protein of Escherichia coli is produced by immunization with purified OmpA or with whole E. coli or Salmonella typhimurium bacteria.

Authors:  R Puohiniemi; M Karvonen; J Vuopio-Varkila; A Muotiala; I M Helander; M Sarvas
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

2.  Measurement of pneumococcal capsular polysaccharide serotype-specific immunoglobulin G in human serum, a method for assigning weight-based units to proposed reference sera.

Authors:  K M Rudolph; A J Parkinson
Journal:  Clin Diagn Lab Immunol       Date:  1994-09

3.  Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S.

Authors:  S A Quataert; C S Kirch; L J Wiedl; D C Phipps; S Strohmeyer; C O Cimino; J Skuse; D V Madore
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

4.  Measurement of immunoglobulin G and M antibodies to type 3 pneumococcal capsular polysaccharide by enzyme-linked immunosorbent assay.

Authors:  B A Carlson; G S Giebink; J S Spika; E D Gray
Journal:  J Clin Microbiol       Date:  1982-07       Impact factor: 5.948

5.  Production of Chlamydia pneumoniae proteins in Bacillus subtilis and their use in characterizing immune responses in the experimental infection model.

Authors:  Ulla Airaksinen; Tuula Penttilä; Eva Wahlström; Jenni M Vuola; Mirja Puolakkainen; Matti Sarvas
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

6.  Pneumococcal antibody levels in patients with acute lung infiltrates.

Authors:  A Löwenberg; J A Snijder; L T vd Weele; H J Sluiter
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

7.  Humoral immunity against Francisella tularensis after natural infection.

Authors:  P Koskela; A Salminen
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

8.  Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Finland.

Authors:  M R Ekman; M Leinonen; H Syrjälä; E Linnanmäki; P Kujala; P Saikku
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

9.  Cell-mediated and humoral immunity induced by a live Francisella tularensis vaccine.

Authors:  P Koskela; E Herva
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

10.  Enzyme-linked immunosorbent assay for detection of capsular antibodies against Haemophilus influenzae type b: comparison with radioimmunoassay.

Authors:  S L Kaplan; E O Mason; G Johnson; R A Broughton; D Hurley; J C Parke
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.